Balversa - Drug Insight, 2019

Balversa - Drug Insight, 2019 report provides comprehensive information of the drug, Balversa. It includes drugs overview, Balversa mechanism of action, clinical trials, regulatory milestones, deals & Balversa's partnerships. It further provides Balversa`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted Balversa sales till 2021. The report also throws light on Balversa market competition and emerging therapies in the same space as Balversa. Balversa SWOT analysis is also featured. * Depending on information availability.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by the research team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

• A comprehensive Balversa overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
• Balversa Patent information in United States (US) and Europe (EU) has been highlighted
• Balversa API manufacturers in United States, Europe, China and India
• The report contains historical and forecasted Balversa sales till 2021
• Comprehensive coverage of the emerging therapies (Phase III) in the space where Balversa operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
• The report also features the Balversa SWOT analysis

Reasons to Buy

• Establish a comprehensive understanding of the drug, Balversa
• Access to Balversa API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around Balversa patents for the major markets- US and EU
• Understand current and future Balversa`s growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for Balversa
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as Balversa
• Identify opportunities in the same area as with Balversa SWOT analysis